Summary - Funding Rounds

Founding Date

2009
Sybenetix is a subsidiary of Nasdaq

Sybenetix Income Statement

Annual

GBPFY, 2018

Revenue

1.1m

Operating expense total

4.0m

EBITDA

(2.9m)

EBITDA margin, %

(271%)

EBIT

(2.9m)

EBIT margin, %

(274%)

Pre tax profit

(3.0m)

Income tax expense

(16.1k)

Net Income

(3.0m)

Sybenetix Balance Sheet

Annual

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

11.9k77.9k145.3k56.9k66.6k88.1k208.9k

Accounts Receivable

16.0k1.0k11.1k135.0k120.0k174.0k60.4k

Current Assets

27.9k78.9k156.3k192.0k278.2k365.1k444.0k

PP&E

6.9k58.3k62.4k12.5k12.0k14.9k129.6k

Total Assets

34.8k137.3k218.7k204.5k290.1k379.9k1.1m

Accounts Payable

29.5k161.3k200.2k269.8k

Current Liabilities

29.5k161.3k200.2k269.8k361.5k449.9k4.2m

Total Liabilities

29.5k161.3k200.2k269.8k361.5k449.9k4.2m

Common Stock

1.0k1.0k1.0k1.0k7.0k8.4k8.4k

Retained Earnings

(25.0k)17.5k(66.3k)(78.4k)(402.6k)(3.4m)

Total Equity

5.3k(24.0k)18.5k(65.3k)(71.4k)(70.0k)(3.1m)

Financial Leverage

6.6 x-5.7 x11.8 x-3.1 x-4.1 x-5.4 x-0.4 x

Sybenetix Cash Flow

Annual

GBPFY, 2018

Net Income

(3.0m)